886973-19-9

Basic information

• Product Name: methyl 2-chloro-5-methylsulfanyl-benzoate
• Synonyms: methyl 2-chloro-5-methylsulfanyl-benzoate
• CAS NO: 886973-19-9
• Molecular Weight: 216.688
• Mol File: 886973-19-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: methyl 2-chloro-5-methylsulfanyl-benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-chloro-5-methylsulfanyl-benzoate(886973-19-9)
• EPA Substance Registry System: methyl 2-chloro-5-methylsulfanyl-benzoate(886973-19-9)

Safety Data

• Hazardous Substances Data: 886973-19-9(Hazardous Substances Data)

Upstream product

• 51546-12-4 2-chloro-5-(methylthio)benzoic acid 
• 74-88-4 methyl iodide 
• 67-56-1 methanol 

Downstream Products

• 151104-30-2 methyl 2-chloro-5-(methylsulfonyl)benzoate 
• 127510-97-8 methyl 2-cyano-5-(methylthio)benzoate 
• 51546-12-4 2-chloro-5-(methylthio)benzoic acid 
• 909419-08-5 methyl 2-chloro-5-(methylsulfinyl)benzoate 
• 909799-70-8 methyl 5-(methylsulfinyl)-2-(1-piperidinyl)benzoate 

Relevant articles and documents

PROTEIN-MACROMOLECULE CONJUGATES AND METHODS OF USE THEREOF

The present disclosure provides protein-macromolecule conjugates, releasable linkers, and macromolecules, as defined herein. The disclosed conjugates provide unique properties that are based at least upon the properties of linker and number of linker-Macromolecule moieties. Also provided herein are a method of synthesis and use of conjugates in treating diseases and disorders.

1,6 - SUBSTITUTED (3R,6R) -3- (2,3-DIHYDRO-1H-INDEN-2-YL)-2,5-PIPERAZINEDIONE DERIVATIVES AS OXYTOCIN RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PRE-TERM LABOUR, DYSMENORRHEA AND ENDOMETRIOSIS

The present invention relates to compound S of Formula (I).

PIPERAZINE DERIVATIVES AS GLYT1 INHIBITORS

The invention provides a compound of formula (I) or a salt or solvate thereof: wherein R1, n, X, Y and Z are as defined in the specification, and uses of such compounds. The compounds inhibit GlyT1 transporters and are useful in the treatment of certain neurological and neuropsychiatric disorders, including schizophrenia.